Qomel Co (SAU:9600) EBIT: ﷼20.4 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SAU:9600 Qomel Co SAU:9600
22 GF Score
Price ﷼49.00
! 3 Warning Signs
View Full Analysis

What is Qomel Co EBIT?

Qomel Co SAU:9600 22 EBIT is ﷼20.4 Mil as of Dec. 2025. GuruFocus rates SAU:9600 with a GF Score™ of 22/100. The stock has 3 warning signs investors should review.

Qomel Co's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was ﷼5.6 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was ﷼20.4 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Qomel Co's annualized ROC % for the quarter that ended in Dec. 2025 was 7.73%. Qomel Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 7.63%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Qomel Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 5.66%.

Qomel Co  (SAU:9600) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Qomel Co's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=13.896 * ( 1 - 16.03% )/( (142.673 + 159.196)/ 2 )
=11.6684712/150.9345
=7.73 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=203.165 - 26.722 - ( 33.77 - max(0, 59.583 - 138.958+33.77))
=142.673

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=218.551 - 38.503 - ( 20.852 - max(0, 57.555 - 133.148+20.852))
=159.196

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Qomel Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=11.11/( ( (64.131 + max(76.957, 0)) + (79.694 + max(70.323, 0)) )/ 2 )
=11.11/( ( 141.088 + 150.017 )/ 2 )
=11.11/145.5525
=7.63 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(76.449 + 19.742 + 8.997) - (26.722 + 0 + 1.509)
=76.957

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(78.079 + 19.075 + 15.142) - (38.503 + 0 + 3.47)
=70.323

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Qomel Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=20.418/360.860
=5.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qomel Co EBIT Related Terms

Qomel Co EBIT Historical Data

* Premium members only.

The historical data trend for Qomel Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qomel Co EBIT Chart

Qomel Co Annual Data
Trend Dec23 Dec24 Dec25
EBIT
20.68 27.03 20.42

Qomel Co Semi-Annual Data
Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial 13.50 12.82 14.21 14.86 5.56

Qomel Co EBIT Competitor Comparison

For the Pharmaceutical Retailers subindustry, Qomel Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qomel Co EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Qomel Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Qomel Co's EV-to-EBIT falls into.


SAU:9600
22GF Score
Qomel Co SAU:9600
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Qomel Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was ﷼20.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ﷼20.4 Mil mean?
Qomel Co (SAU:9600) has a EBIT of ﷼20.4 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Qomel Co.
Is Qomel Co's EBIT too high?
Qomel Co's current EBIT is ﷼20.4 Mil. Overall, Qomel Co has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Qomel Co's EBIT compare to competitors?
Qomel Co's EBIT of ﷼20.4 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Qomel Co. Qomel Co's current EBIT is ﷼20.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qomel Co stock overvalued right now?
Qomel Co (SAU:9600) has a current EBIT of ﷼20.4 Mil. The current EBIT is ﷼20.4 Mil. Qomel Co's overall GF Score™ is 22/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Qomel Co (SAU:9600), the current EBIT is ﷼20.4 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Qomel Co Business Description

Address 3221 Prince Mamdouh bin Abdul Aziz Street, Sulaymaniyah District, Riyadh, SAU
Qomel Co is a Saudi Arabian-based healthcare company that provides high-quality medicines and innovative medical services whose core business focuses on institutional and government supply through a professional field force and an in-depth knowledge of the local business environment They offer services such as pharmaceutical and medical supplies.
22GF Score

Get the complete analysis for SAU:9600

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼49.00
Price